Takeda
Samsung Bioepis collaborates to make inroads into original drugs
August 21, 2017Research and Development, Sales and Marketing Samsung Bioepis, Takeda, biotech, drugs, pharma, pharmaceutical
Thus far, Samsung Bioepis has made its name by being a thorn in the side of the producers of original …
Takeda strikes partnership to develop single-drug cancer combo immunotherapies
August 14, 2017Medical Communications, Research and Development, Sales and Marketing Cancer, Takeda, immunotherapy, medicine, pharma, pharmaceuticals
Japanese pharma giant Takeda has announced that it is to partner up with US-based Shattuck Labs in a collaboration to …
Takeda reveals collaboration aimed at bolstering oncology pipeline
August 8, 2017Manufacturing and Production, Sales and Marketing Molecular Templates, Takeda, biotech, drugs, oncology, pharma, pharmaceutical
It is widely known that Takeda is keen to build its portfolio in oncology and it has made another move …
Merkel opens Takeda’s new production facility in Germany
June 20, 2017Manufacturing and Production Germany, Takeda, merkel
Angela Merkel was part of the opening ceremony that saw Takeda announce the completion of a third production space in …
Takeda launches construction of €40 million Dublin facility
June 7, 2017Manufacturing and Production, Research and Development Dublin, Ireland, Takeda
Takeda has officially launched the construction of a new €40 million expansion of its production facility in Dublin, Ireland, with …
Pharmaceutical companies and patient advocacy groups: Natural allies in the support of patients
May 25, 2017Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Takeda, Takeda oncology, patient advocacy
As published in the special Market Access section of the latest issue of Pharmafocus, Liz Lewis, Chief Counsel & Compliance …
The June 2017 issue of Pharmafocus is now live!
May 23, 2017Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing ABPI, Pharmafocus, Roche, Takeda, UK, brexit, data management, market access, neurological disorders
The latest edition of Pharmafocus is available to read online now!
Takeda completes enrollment for largest-ever study of dengue vaccine
April 6, 2017Research and Development Takeda, clinical trial, dengue
Takeda announced that it had completed the enrolment for the largest clinical trial in its history, having enrolled 20,100 children …
Takeda lays off more than half of Ariad’s US staff
March 31, 2017Medical Communications Ariad Pharmaceuticals, Takeda
Takeda acquired Ariad Pharmaceuticals at the beginning on the year for $5.2 billion, a price many thought was relatively high …
Takeda collaborates to launch wearable-tech depression study
February 23, 2017Medical Communications, Research and Development Takeda, depression, mental health, wearable tech
Takeda and Cognition Kit Limited have announced a collaborative venture to trial the use of an app in the monitoring …
Faulty batch of Takeda’s paracetamol discovered in Denmark
February 21, 2017Manufacturing and Production Denmark, Takeda
Takeda has announced a recall of a batch of its paracetamol tablets, named Pamol, in Denmark after two packs were …
Takeda and TiGenix announce successful trial of Crohn’s disease drug
February 17, 2017Medical Communications, Sales and Marketing Takeda, TiGenix
Takeda and TiGenix announced Phase 3 results from a trial looking into the investigational compound Cx601, a treatment for refractory …
Takeda discusses the importance of patient-focused market access
February 3, 2017Medical Communications, Sales and Marketing Takeda, oncology
With World Cancer Day on 4 February, Takeda Oncology’s Liviu Niculescu and Stephen J. Noga talk to Pharmafile.com on the …
Takeda UK names new market access director
January 25, 2017Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Takeda
Takeda UK has appointed Peter Wheatley Price to the role of market access director, where he will also sit on …
22 pharma companies join forces for global non-communicable disease initiative
January 18, 2017Research and Development BMS, Celgene, Eisai, Eli Lilly, GSK, J&J, JJ, MSD, Merck, Novartis, Pfizer, Roche, Sanofi, Takeda
The World Economic Forum Annual Meeting in Switzerland has seen the launch of Access Accelerated, a global initiative consisting of …
Latest content
Jennings becomes President of Beckman Coulter Diagnostics
Boyds expands Regulatory Affairs team to support growing demand
Sterling doubles ADC manufacturing capacity at Welsh facility
Femtosecond laser cuts lung tumour margin assessment time
